Literature DB >> 1397210

Is Pneumocystis carinii a deep mycosis-like agent?

E Dei-Cas1, J C Cailliez, F Palluault, E M Aliouat, E Mazars, B Soulez, J Suppin, D Camus.   

Abstract

Pneumocystis carinii is a widespread eukaryotic microorganism found in the lungs of healthy mammals, including humans. It is able to proliferate extensively in the alveoli, becoming an important agent of severe pneumonitis in immunosuppressed hosts, especially in persons suffering from AIDS. The taxonomic position of P. carinii is uncertain. Typical cytoplasmic organelles of eukaryotic cells have been found and described in the parasite. Biochemical research is hindered by the lack of an efficient in vitro culture system. Results of comparative study of nucleic acid sequences suggest that Pneumocystis is a fungus. However, ultrastructural, biochemical and nucleic acid homology insights appear as clearly insufficient to class Pneumocystis. Pneumocystis infection might be acquired, as deep mycoses, from environmental sources through the respiratory tract. Thus, the hypothesis of an environmental stage of the parasite must be considered. Pneumocystis might be seen as a widespread pathogenic dimorphous fungus. As fungal agents, P. carinii is able to disseminate from the infected lung to other organs. However, deep mycoses and pneumocystosis induce different histopathological changes in the host. Furthermore, deep fungal infections, unlike pneumocystosis, cannot be transmitted from one infested host to another one. Beside these two aspects, pneumocystosis shares many features with deep mycoses. Research on the epidemiology of pneumocystosis is needed.

Entities:  

Mesh:

Year:  1992        PMID: 1397210     DOI: 10.1007/bf00158583

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  73 in total

1.  Morphology of Pneumocystis carinii and activation of the plasmalemmal vesicular system in alveolar epithelial cells of the host. An ultrastructural study.

Authors:  M H Nielsen; O P Settnes
Journal:  APMIS       Date:  1991-03       Impact factor: 3.205

2.  RNA homology and the reclassification of Pneumocystis.

Authors:  J K Frenkel; M S Bartlett; J W Smith
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Jan-Feb       Impact factor: 2.803

3.  Absence of pneumocystosis in Ugandan AIDS patients.

Authors:  D Serwadda; R Goodgame; S Lucas; G Kocjan
Journal:  AIDS       Date:  1989-01       Impact factor: 4.177

4.  Freeze-fracture localization of filipin-sterol complexes in plasma- and cyto-membranes of Pneumocystis carinii.

Authors:  H Yoshikawa; H Morioka; Y Yoshida
Journal:  J Protozool       Date:  1987-05

Review 5.  Parasitic adaptation of pathogenic fungi to mammalian hosts.

Authors:  E Dei Cas; A Vernes
Journal:  Crit Rev Microbiol       Date:  1986       Impact factor: 7.624

6.  Novel immunofluorescence test for Pneumocystis carinii.

Authors:  A K Trull; R E Warren; S Thiru
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

7.  Identification of Pneumocystis carinii chromosomes and mapping of five genes.

Authors:  B Lundgren; R Cotton; J D Lundgren; J C Edman; J A Kovacs
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

8.  Does Pneumocystis carinii occur in Kenya?

Authors:  L Griffin; S B Lucas
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

9.  High osmotic pressure for Pneumocystis carinii London Resin White embedding enables fine immunocytochemistry studies: I. Golgi complex and cell-wall synthesis.

Authors:  F Palluault; B Soulez; C Slomianny; E Dei-Cas; J Y Cesbron; D Camus
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

10.  No detection of characteristic fungal protein elongation factor EF-3 in Pneumocystis carinii.

Authors:  H C Jackson; D Colthurst; V Hancock; M S Marriott; M F Tuite
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

View more
  1 in total

Review 1.  Molecular epidemiology of Pneumocystis carinii pneumonia.

Authors:  C B Beard; T R Navin
Journal:  Emerg Infect Dis       Date:  1996 Apr-Jun       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.